BFRIW Latest Press Releases

-- November 6, 2026 --

Biofrontera Inc. to Report Third Quarter 2026 Financial Results on November 13, 2026 Globe Newswire 6:08 PM

-- October 8, 2026 --

Biofrontera Submits Supplemental New Drug Application to FDA to Expand Ameluz Red Light PDT to Actinic Keratoses on the Full Body Globe Newswire 9:22 AM

-- September 14, 2026 --

Biofrontera Announces FDA Approval of Ameluz Red Light PDT for the Treatment of Superficial Basal Cell Carcinoma Globe Newswire 9:26 AM

-- August 13, 2026 --

Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth Globe Newswire 8:51 AM

-- August 5, 2026 --

Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026 Globe Newswire 4:15 PM

Market Data Delayed 15 Minutes